These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 24317363

  • 1. miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.
    Yu J, Lu Y, Cui D, Li E, Zhu Y, Zhao Y, Zhao F, Xia S.
    Oncol Rep; 2014 Feb; 31(2):910-8. PubMed ID: 24317363
    [Abstract] [Full Text] [Related]

  • 2. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
    Zhang G, Tian X, Li Y, Wang Z, Li X, Zhu C.
    Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
    [Abstract] [Full Text] [Related]

  • 3. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
    Ren D, Wang M, Guo W, Zhao X, Tu X, Huang S, Zou X, Peng X.
    Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
    Katz B, Reis ST, Viana NI, Morais DR, Moura CM, Dip N, Silva IA, Iscaife A, Srougi M, Leite KR.
    PLoS One; 2014 Apr; 9(11):e113700. PubMed ID: 25409297
    [Abstract] [Full Text] [Related]

  • 5. miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines.
    Zhu C, Li J, Ding Q, Cheng G, Zhou H, Tao L, Cai H, Li P, Cao Q, Ju X, Meng X, Qin C, Hua L, Shao P, Yin C.
    Prostate; 2013 Jul; 73(10):1082-9. PubMed ID: 23460133
    [Abstract] [Full Text] [Related]

  • 6. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
    Xiang J, Bian C, Wang H, Huang S, Wu D.
    J Exp Clin Cancer Res; 2015 Jan 31; 34(1):8. PubMed ID: 25636908
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.
    Xia L, Han Q, Chi C, Zhu Y, Pan J, Dong B, Huang Y, Xia W, Xue W, Sha J.
    Biomed Pharmacother; 2020 Apr 31; 124():109863. PubMed ID: 31986411
    [Abstract] [Full Text] [Related]

  • 8. miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.
    Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N, Wang Z, Hua L, Wang X.
    Mol Cell Biochem; 2011 Apr 31; 350(1-2):207-13. PubMed ID: 21197560
    [Abstract] [Full Text] [Related]

  • 9. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
    Patel N, Garikapati KR, Makani VKK, Nair AD, Vangara N, Bhadra U, Pal Bhadra M.
    PLoS One; 2018 Apr 31; 13(2):e0190245. PubMed ID: 29394261
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
    Rajendiran S, Parwani AV, Hare RJ, Dasgupta S, Roby RK, Vishwanatha JK.
    Mol Cancer; 2014 Nov 19; 13():250. PubMed ID: 25406943
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
    Zhou L, Zhang WG, Wang DS, Tao KS, Song WJ, Dou KF.
    Oncol Rep; 2014 Oct 19; 32(4):1734-40. PubMed ID: 25109303
    [Abstract] [Full Text] [Related]

  • 12. miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells.
    Huang S, Guo W, Tang Y, Ren D, Zou X, Peng X.
    Oncol Rep; 2012 Nov 19; 28(5):1831-7. PubMed ID: 22948942
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.
    Feng B, Wang R, Song HZ, Chen LB.
    Cancer; 2012 Jul 01; 118(13):3365-76. PubMed ID: 22139708
    [Abstract] [Full Text] [Related]

  • 15. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
    Liu S, Tetzlaff MT, Cui R, Xu X.
    Am J Pathol; 2012 Nov 01; 181(5):1823-35. PubMed ID: 22982443
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.
    Guo S, Xu X, Tang Y, Zhang C, Li J, Ouyang Y, Ju J, Bie P, Wang H.
    Cancer Lett; 2014 Mar 01; 344(1):40-46. PubMed ID: 24252251
    [Abstract] [Full Text] [Related]

  • 19. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
    Mao Y, Chen H, Lin Y, Xu X, Hu Z, Zhu Y, Wu J, Xu X, Zheng X, Xie L.
    Oncol Rep; 2013 Jul 01; 30(1):327-33. PubMed ID: 23670210
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.